MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 255 filers reported holding MYRIAD GENETICS INC in Q2 2016. The put-call ratio across all filers is 3.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,000 | -33.3% | 131 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | -40.0% | 131 | -23.4% | 0.00% | – |
| Q2 2016 | $5,000 | -16.7% | 171 | 0.0% | 0.00% | – |
| Q1 2016 | $6,000 | -14.3% | 171 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | +16.7% | 171 | 0.0% | 0.00% | – |
| Q3 2015 | $6,000 | 0.0% | 171 | -7.1% | 0.00% | – |
| Q2 2015 | $6,000 | -66.7% | 184 | -64.1% | 0.00% | -100.0% |
| Q1 2015 | $18,000 | +800.0% | 512 | +621.1% | 0.00% | – |
| Q4 2014 | $2,000 | -33.3% | 71 | 0.0% | 0.00% | – |
| Q3 2014 | $3,000 | 0.0% | 71 | 0.0% | 0.00% | – |
| Q2 2014 | $3,000 | -25.0% | 71 | -50.0% | 0.00% | – |
| Q1 2014 | $4,000 | 0.0% | 142 | -21.5% | 0.00% | -100.0% |
| Q4 2013 | $4,000 | +100.0% | 181 | +154.9% | 0.00% | – |
| Q3 2013 | $2,000 | 0.0% | 71 | 0.0% | 0.00% | – |
| Q2 2013 | $2,000 | – | 71 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |